Rose is a managing editor at The American Journal of Managed Care® (AJMC®).
She has a BA in journalism & media studies and Spanish from Rutgers University. You can connect with Rose on LinkedIn.
Targeting β Cells May Hold Promise for Preventing and Treating T1D
July 7th 2022Although the autoimmune response that reduces β cell numbers has often been the focus of research in type 1 diabetes (T1D), findings from a new study suggest proinflammatory signaling in islet β cells may play a significant role in disease progression.
Read More
Hypomethylating Agents Can Produce Long Remission of MPNs but May Contribute to Morbidity, Mortality
July 4th 2022Hypomethylating agents are a widely used treatment option in acute myeloid leukemia secondary to myeloproliferative neoplasms (MPNs), but careful monitoring of thromboembolic risk is needed for optimal outcomes.
Read More
Assessing Longitudinal Trends in Essential Thrombocythemia, Polycythemia Vera Blood Counts
July 2nd 2022A recent study identified trends in blood counts, but did not find statistically significant associations between achieving hematological remission and clinical outcomes in polycythemia vera (PV) or essential thrombocythemia (ET).
Read More
Population-Based Study Finds Racial Disparities in MDS Outcomes
June 29th 2022Research presented at the 2022 American Society of Clinical Oncology Annual Meeting shows White patients with myelodysplastic syndrome (MDS) have worse overall survival outcomes than African American patients, contrary to previous findings in other cancer types.
Read More
Risk Factors for Hemophilia-Related Bleeding From Prophylaxis Explored in New Study
June 28th 2022Creating and validating effective risk assessment models could help facilitate appropriate prophylaxis for hemophilia, but more research is needed to confirm the prognostic value of various clinical risk factors and biomarkers.
Read More
Interim Phase 2 Trial Results Show Quadruplet Regimen Tolerable, Effective in MM
June 25th 2022Early results of a multicenter phase 2 trial exploring the efficacy of daratumumab, pomalidomide, dexamethasone, and ixazomib treatment suggest the regimen is safe and effective in relapsed or refractory multiple myeloma (MM).
Read More
Transfusion-Dependent Patients With MDS Vary in Treatment Experiences, Preferences
June 17th 2022Transfusion dependence is common for patients with myelodysplastic syndromes (MDS), but real-world data show inconsistent patient experiences and varied transfusion practices between countries.
Read More
Major Adverse Cardiac Events Related to ICI Treatment Explored in New Study
June 17th 2022Major adverse cardiac events are rare but serious in patients treated with immune checkpoint inhibitors (ICIs), and increased awareness is crucial to identify and treat these conditions in a timely manner.
Read More
Parental Age May Be Linked With Childhood Cancer Risk, but More Research Is Needed
June 14th 2022A recent meta-analysis aimed to clarify the relationship between parental age and solid tumor pediatric cancers, but more studies are necessary to overcome the limitations of available research.
Read More
Study Examines T1D Eating Patterns of Youth After COVID-19 Lockdowns in Italy
June 10th 2022Findings of a study on children and adolescents with type 1 diabetes (T1D) in Italy suggest lockdown periods during COVID-19 did not increase disordered eating symptoms or adversely affect disease management.
Read More
Novel Prognostic Biomarkers Indicate Prognosis in Acute Myeloid Leukemia
June 6th 2022A novel prognostic model based on N 6-methyladenosine-associated long non-coding RNAs demonstrated accuracy in determining high- and low-risk disease, suggesting the associated risk value may have potential as a novel biomarker.
Read More
Study: Suggested Cyclosporine Levels Posttransplant May Be Too Low to Prevent GVHD
June 4th 2022Preventing graft-versus-host disease (GVHD) after allogeneic stem cell transplant is a key aspect of patient management, but current cyclosporine concentration guidelines may not be sufficient, according to a recent study.
Read More